Amgen, with Microsoft Copilot Studio, developed a custom R&D agent in six weeks. This story illustrates how autonomous agents streamline workflows, innovate faster, and deliver measurable business value. Reach out to R.B.Hall Associates, LLC to learn more.
What is Catalyst Copilot?
Catalyst Copilot is an intelligent agent developed by Amgen's knowledge management team using Microsoft Copilot Studio. It is designed to help drug developers quickly find and analyze vast amounts of information, reports, and resources. With its Q&A interface, Catalyst Copilot allows users to ask questions in natural language, making it easier to access the information needed to advance drug development.
How long did it take to build Catalyst Copilot?
The development of Catalyst Copilot took approximately six weeks. The main goal was to leverage AI to streamline the process of sorting and analyzing Amgen's extensive collection of curated resources, ultimately enabling drug developers to access critical information more efficiently and shorten the discovery cycle.
What impact does AI have on R&D at Amgen?
AI is transforming the research and development process at Amgen by enabling better science at scale. It helps automate parts of the scientific process and distills data to provide deeper insights. By making information more accessible and allowing for quicker analysis, AI tools like Catalyst Copilot are helping to reduce the time it takes to develop new therapies, ultimately supporting Amgen's mission to serve patients more effectively.
Sign in with LinkedIn